Streetbeat News

Earnings

NVVE

Nuvve Holding (NASDAQ:NVVE) reported Q2 losses of $(0.30) per share, beating the analyst consensus estimate of $(0.38) by 21.05%. This is a 28.57% increase over losses from the same period last year. The company also reported quarterly sales of $2.12 million, beating the analyst consensus estimate of $1.30 million by 63.08%. This is a 62.83% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:04 pm

SVT

Servotronics reported Q2 losses of $3.86 per share, a 1069.7% decrease YoY. However, the company's sales increased by 21.84% to $10.60 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:04 pm

FGH

FG Group Holdings (AMEX:FGH) reported Q2 losses of $(0.27) per share, a 6.9% improvement from $(0.29) per share YoY. Sales for the quarter were $18.02M, a 97.11% increase from $9.14M YoY.

Portfolio Pulse from vinayak@benzinga.com

August 10, 2023 | 9:04 pm

FGF

FG Finl Gr (NASDAQ:FGF) reported Q2 losses of $(0.35) per share, a 59.77% improvement from $(0.87) per share YoY. The company also reported $2.19 million in sales, a 397.41% increase from $(735.00 thousand) YoY.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:03 pm

HCTI

Healthcare Triangle (NASDAQ:HCTI) reported Q2 losses of $(0.42) per share, a 320% decrease YoY. The company also reported a 26.65% decrease in sales to $8.50 million compared to $11.59 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:03 pm

GEOS

Geospace Technologies (NASDAQ:GEOS) reported Q3 earnings of $0.24 per share, a 147.06% increase YoY. The company also reported $32.72 million in sales, a 58.11% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:02 pm

BIOL

Biolase (NASDAQ:BIOL) reported Q2 losses of $(4.24) per share, beating the analyst consensus estimate of $(5.33) by 20.45 percent. However, the company's quarterly sales of $14.29 million missed the analyst consensus estimate of $15.36 million by 6.99 percent.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:02 pm

TPST

Tempest Therapeutics reported Q2 earnings per share (EPS) of $(0.54), missing the estimated $(0.52).

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:02 pm

OBIO

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported Q2 losses of $(0.35) per share, a 54.55% improvement from $(0.77) per share losses in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:01 pm

SVM

Silvercorp Metals reported Q1 adjusted earnings of $0.07 per share, in line with analyst estimates. However, the company's quarterly sales of $60.01 million missed the consensus estimate of $60.10 million by 0.16 percent. This represents a 12.5 percent decrease in earnings and a 5.64 percent decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:01 pm